Related Experiment Videos
Titin mutations as the molecular basis for dilated cardiomyopathy
Manatsu Itoh-Satoh1, Takeharu Hayashi, Hirofumi Nishi
1Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Biochemical and Biophysical Research Communications
|February 16, 2002
Summary
Mutations in the titin gene, a key cardiac sarcomere protein, are linked to dilated cardiomyopathy (DCM). Researchers identified four titin mutations, impacting protein interactions and potentially causing DCM in some patients.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Protein Biochemistry
Background:
- Dilated cardiomyopathy (DCM) is a complex heart condition involving ventricular enlargement and impaired pumping function.
- Genetic factors, particularly mutations in sarcomeric protein genes, are increasingly recognized as causes of DCM.
- The giant protein titin, a crucial sarcomere component, is a candidate gene for familial DCM.
Purpose of the Study:
- To investigate the role of titin gene mutations in patients with dilated cardiomyopathy.
- To identify specific titin mutations associated with DCM and elucidate their functional consequences.
Main Methods:
- Genetic analysis of patients with DCM to identify titin gene mutations.
- Functional assays, including yeast two-hybrid studies, to assess the impact of identified mutations on protein interactions.
- Analysis of mutations in the Z-line and cardiac-specific N2-B regions of titin.
Main Results:
- Four potential disease-associated titin mutations were identified in DCM patients.
- Mutations Val54Met and Ala743Val in the Z-line region reduced binding affinity to T-cap/telethonin and alpha-actinin, respectively.
- Two mutations in the N2-B region were found, including a nonsense mutation (Glu4053ter) likely resulting in a truncated protein.
Conclusions:
- Titin gene mutations represent a potential cause of dilated cardiomyopathy in a subset of affected individuals.
- Specific titin mutations can disrupt sarcomere integrity and function by impairing interactions with other sarcomeric proteins.
- Further research into titin's role in DCM pathogenesis is warranted.